Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
Caribou Biosciences, Inc. (CRBU)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 593.7% | 544.4% | 278.5% | 408.3% |
| General and administrative | 274.5% | 253.4% | 113.7% | 284.3% |
| EBITDA | -756.5% | -687.6% | -285.0% | -579.7% |
| Depreciation | 11.7% | 10.3% | 7.3% | 13.0% |
| EBIT | -768.2% | -697.8% | -292.2% | -592.7% |
| Pre-tax income | -717.3% | -693.9% | -292.3% | -535.0% |
| Income taxes | 0.5% | 3.3% | -14.7% | -130.2% |
| Net income | -717.8% | -697.3% | -277.6% | -404.8% |
|